Inaktiver Wert

Transition Therapeutics Inc Aktie

Aktien

Dauer

Zeitraum

Stil

Transition Therapeutics : Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.	26.08.16
Transition Therapeutics : Receives Notification From NASDAQ	03.06.16
Transition Therapeutics : Announces Third Quarter Fiscal 2016 Financial Results	11.05.16
Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST	09.05.16
Transition Therapeutics : Provides Update on Type 2 Diabetes Drug Candidate TT401	18.04.16

Manager	Titel	Alter	Seit
Antonio F. Cruz CEO	Chief Executive Officer	71	06.07.98

Aufsichtsräte	Titel	Alter	Seit
Antonio F. Cruz CEO	Chief Executive Officer	71	06.07.98

Sektor

	% 1. Jan.	Kap.
CSL LIMITED	+0,10 %	91,42 Mrd.
SAMSUNG BIOLOGICS CO.,LTD.	+2,76 %	41,08 Mrd.
BIOGEN INC.	-9,06 %	34,26 Mrd.
UCB	+54,50 %	25,27 Mrd.
BIOMARIN PHARMACEUTICAL INC.	-16,61 %	15,27 Mrd.
INCYTE CORPORATION	-9,14 %	12,81 Mrd.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12,11 %	11,6 Mrd.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,61 %	11,42 Mrd.
SWEDISH ORPHAN BIOVITRUM AB	+4,94 %	9,16 Mrd.